MedPath

Retrospective study on real-world clinical application, effect and safety of Keluoxin Capsule

Not Applicable
Recruiting
Conditions
Diabetic nephropathy
Registration Number
ITMCTR2100004697
Lead Sponsor
Shanghai University of TCM
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

For objective 1, the inclusion criteria:
Patients who were prescribed Keluoxin caspule during Jan 2017 and Sep 2020.(including outpatient and inpatient patients).
For objective 2,3, the inclusion criteria:
1.Patients who were diagnosed with diabetic kidney disease or diabete mellitus during Jan 2017 and Sep 2020.(including outpatient and inpatient patients);
2.Had at least one follow-up visit within 1 year after baseline visit.

Exclusion Criteria

1.loss of baseline information(age,gender).
2.loss of prescription information(usage, dosage, course).

Study & Design

Study Type
Observational study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.